Top Abstract Purchase Related
Home
>
Node
>
Subnode

The in situ carcinomas of the breast

Strah, K.M.; Love, S.M.

Journal of the American Medical Women's Association 47(5): 165-168

1992

ISSN/ISBN: 0098-8421
PMID: 1460220
Document Number: 401629
In situ carcinoma of the breast is being diagnosed with greater frequency on breast biopsies. Of the two types of CIS, lobular carcinoma in situ is considered a marker for increased risk of developing breast cancer in either breast, and treatment options are based on different philosophies of careful follow-up vs preventive surgery. Ductal carcinoma in situ is a direct precursor to invasive carcinoma and the variety of treatments available reflect the need to completely excise this lesion. Several trials are now in progress to define the roles of surgery, radiation, and hormonal manipulation in the treatment of both types of CIS.

Document emailed within 1 workday
Secure & encrypted payments

Sidoni, A.; Ferri, I.; Cavaliere, A.; Bellezza, G.; Scheibel, M.; Bucciarelli, E. 2006: Detection of HER-2/neu (c-erbB-2) overexpression and amplification in breast carcinomas with ambiguous immunohistochemical results. A further contribution to defining the role of fluorescent in situ hybridization Anticancer Research 26(3b): 2333-2337
Levêque, J.; Poulain, P.; Berger, D.; Broux, P.L.; Grall, J.Y.; Giraud, J.R.; Kérisit, J. 1991: Intraductal carcinomas in situ. Retrospective study of 21 cases and review of the literature Journal de Gynecologie Obstetrique et Biologie de la Reproduction 20(2): 149-162
Di Martino, L.; Tarquini, A.; Mitchell, I.; Deshpande, N. 1980: Hormone synthesis by primary breast carcinomas and prognosis in human breast cancer Tumori 66(2): 197-203
Friedrich, M.; Villena-Heinsen, C.; He, J.; Mink, D.; Reichrath, J.; Reitnauer, K.; Schmidt, W. 1998: Correlation between immunoreactivity for transglutaminase K and for markers of proliferation and differentiation in normal breast tissue and breast carcinomas European Journal of Gynaecological Oncology 19(5): 444-448
Hwang, T.Z.; Jin, Y.T.; Tsai, S.T. 1998: EBER in situ hybridization differentiates carcinomas originating from the sinonasal region and the nasopharynx Anticancer Research 18(6b): 4581-4584
Mincheva, A.; Karag'ozov, I.; Slavchev, B.; Vasilev, N.; Makaveeva, V. 1992: The demonstration of HPV DNA in cervical intraepithelial neoplasms and in invasive carcinomas of the cervix uteri by DNA-DNA in situ hybridization Akusherstvo i Ginekologiia 31(1): 20-22
Mariuzzi, L.; Mombello, A.; Rucco, V.; Morelli, L.; Zamò, A.; Thompson, D.; Vaught, L.; Bartels, H.G.; Mariuzzi, G.; Bartels, P.H. 2000: Quantitative study of ductal breast cancer progression: signatures of nuclei in proliferating breast lesions and in situ cancer Advances in Clinical Pathology: the Official Journal of Adriatic Society of Pathology 4(2): 87-97
Niveditha, S.R.; Bajaj, P. 2003: Vimentin expression in breast carcinomas Indian Journal of Pathology and Microbiology 46(4): 579-584
Romanelli, R.; Toncini, C.; Bandelloni, R. 1984: Giant cell carcinomas of the breast Minerva Ginecologica 36(11): 711-718
Petignat, P.; Usel, M.; Gauthier, P.; Popowski, Y.; Pelte, M.F.; Bouchardy, C.; Verkooijen, H.M. 2008: Outcome of uterine clear cell carcinomas compared to endometrioid carcinomas and poorly-differentiated endometrioid carcinomas European Journal of Gynaecological Oncology 29(1): 57-60
Bofinger, H. 1972: Surgical technics in the treatment of breast carcinomas Zeitschrift für Arztliche Fortbildung 66(3): 169-170
Cattelani, L.; Rossi, G.; Piccolo, P.; Bobbio, P. 1998: The surgical treatment of nonpalpable breast carcinomas Acta Bio-Medica de l'Ateneo Parmense 69(1-2): 7-11
Maeda, T.; Enomoto, K.; Sakurai, K.; Amano, S. 2010: A case of multiple breast mucinous carcinomas Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(12): 2772-2774
Georgiev, C.; Damianov, D.; Iliev, I.; Todorov, T.; Boshnakova, T. 1999: Mucinous breast carcinomas with neuroendocrine differentiation Khirurgiia 55(5): 22-24
Fentiman, I. 1992: Ductal carcinoma in situ of the breast Practitioner 236(1514): 502
Kitinya, J.N.; Mbonde, M.P.; Guthe, H.J.; Akslen, L.A. 1994: Ploidy and proliferation rates in carcinomas of the breast in Tanzania East African Medical Journal 71(3): 195-198
Ozzello, L.; Gump, F.E. 1985: The management of patients with carcinomas in fibroadenomatous tumors of the breast Surgery Gynecology and Obstetrics 160(2): 99-104
Khwaja, T.A. 1982: 3-deazaguanine, a candidate drug for the chemotherapy of breast carcinomas? Cancer Treatment Reports 66(10): 1853-1858
Benson, A.B. 2001: Oral eniluracil/5-FU for advanced colon and breast carcinomas Oncology 15(1 Suppl 2: 57-63; Discussion 64
Pervez, S. 1994: Why to measure estrogen receptor status in breast carcinomas? JPMA. Journal of the Pakistan Medical Association 44(6): 132-133